Suchergebnisse - "Chen, Xuejun"
-
1
Autoren: et al.
Quelle: Frontiers in Plant Science; 2025, p1-10, 10p
Schlagwörter: FLAVONOIDS, TOBACCO, METABOLOMICS, LIFE cycles (Biology), METABOLITES, MULTIOMICS, TRANSCRIPTOMES, PLANT biomass
-
2
Autoren: et al.
Quelle: BMC Medical Imaging; 11/26/2025, Vol. 25 Issue 1, p1-8, 8p
-
3
Autoren: et al.
Quelle: ENT: Ear, Nose & Throat Journal; Nov2025, Vol. 104 Issue 11, pNP748-NP755, 8p
Schlagwörter: LARYNGEAL physiology, SQUAMOUS cell carcinoma, TRACHEAL cartilage, TRACHEOTOMY, EARLY medical intervention, CANCER relapse, NASOENTERAL tubes, LARYNGEAL tumors, HEAD & neck cancer, COMPUTED tomography, TREATMENT effectiveness, CANCER patients, RETROSPECTIVE studies, DESCRIPTIVE statistics, MEDICAL device removal, LONGITUDINAL method, LARYNGOSCOPY, LASER therapy, TRACHEOTOMY equipment, LARYNGECTOMY, PLASTIC surgery, GENERAL anesthesia, TUMOR classification, DATA analysis software, POSTOPERATIVE period, GLOTTIS
Geografische Kategorien: CHINA
-
4
Autoren: et al.
Quelle: FEBS Open Bio; Jul2025, Vol. 15 Issue 7, p1041-1053, 13p
-
5
Autoren: et al.
Quelle: BMC Pulmonary Medicine; 7/29/2025, Vol. 25 Issue 1, p1-11, 11p
Schlagwörter: LUNG cancer, DEEP learning, SENSITIVITY & specificity (Statistics), AUTOANTIBODIES, STATISTICAL accuracy, DIAGNOSIS, COMPUTED tomography
Geografische Kategorien: CHINA
-
6
Autoren: et al.
Quelle: Frontiers in Plant Science; 2025, p1-12, 12p
-
7
Autoren: et al.
Quelle: Oncologist; Jul2025, Vol. 30 Issue 7, p1-11, 11p
Schlagwörter: THERAPEUTIC use of monoclonal antibodies, PATIENT safety, RESEARCH funding, CLINICAL trials, PROGRAMMED death-ligand 1, SEVERITY of illness index, TREATMENT effectiveness, DESCRIPTIVE statistics, METASTASIS, IMMUNE checkpoint inhibitors, GENES, DOSE-effect relationship in pharmacology, INTRAVENOUS therapy, ADVERSE health care events, DRUG tolerance, EVALUATION
-
8
Autoren: et al.
Quelle: Advanced Science; 7/10/2024, Vol. 11 Issue 26, p1-15, 15p
Schlagwörter: BISPECIFIC antibodies, MONOCLONAL antibodies, HIV, CD4 antigen, IMMUNOGLOBULINS
-
9
Autoren: et al.
Quelle: AAPS PharmSciTech; Jun2025, Vol. 26 Issue 5, p1-13, 13p
-
10
Autoren: et al.
Quelle: Cancer Imaging; 4/8/2025, Vol. 25 Issue 1, p1-9, 9p
-
11
Autoren: et al.
Quelle: Infection & Drug Resistance; Sep2024, Vol. 17, p4101-4112, 12p
-
12
Autoren: et al.
Quelle: Insights into Imaging; 10/31/2024, Vol. 15 Issue 1, p1-13, 13p
-
13
Autoren: et al.
Quelle: Advanced Science; 11/20/2025, Vol. 12 Issue 43, p1-22, 22p
-
14
Autoren: et al.
Quelle: BMC Plant Biology; 11/3/2025, Vol. 25 Issue 1, p1-17, 17p
-
15
Autoren: et al.
Quelle: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
-
16
Autoren: et al.
Quelle: Insights into Imaging; 3/23/2025, Vol. 16 Issue 1, p1-10, 10p
-
17
Autoren: et al.
Quelle: Journal of Magnetic Resonance Imaging; Mar2025, Vol. 61 Issue 3, p1482-1491, 10p
-
18
Autoren: et al.
Quelle: Insights into Imaging; 6/13/2024, Vol. 15 Issue 1, p1-11, 11p
-
19
Autoren: et al.
Quelle: Science Translational Medicine; 5/22/2024, Vol. 16 Issue 748, p1-16, 16p
Schlagwörter: BOOSTER vaccines, VACCINATION, VACCINE effectiveness, HIV infections, IMMUNOGLOBULINS
-
20
Autoren: et al.
Quelle: Science Translational Medicine; 1/17/2024, Vol. 16 Issue 730, p1-9, 9p
Schlagwörter: RHESUS monkeys, PEPTIDES, IMMUNOGLOBULINS, VACCINE development, HIV
Full Text Finder
Nájsť tento článok vo Web of Science